Maintenance of remission in GPA/MPA. RTX for 48 months sounds good to me. #EULAR2024 https://t.co/5YGwOHhCuX

• https://twitter.com/NoufAhmedAlham2/status/1801589237952782644/photo/1

#wasup in #GCA? #upadacitinib +RCT in #temporal #arteritis LBA0001 Residual #inflammation in 1/3 of pts at 6 mo #Rx w #TCZ on repeat TA Bx OP0621 #PMR cases #Leflunomide beats #MTX for #pred sparing ⬇️relapses But MTX dose was low POS0280 #EULAR2024 @RheumNow @eular_org

#EULAR2024 POS1420 A cohort study with 1/3 each with GCA, PMR and GCA+PMR found that at 6mth, 16% of patients had new diabetes/diabetes worsened. Worse in GCA+PMR group with the greatest GC accumulation. Call for better GC-sparing strategy @RheumNow https://t.co/ex7u83bVfj

• https://twitter.com/Yuz6Yusof/status/1801662770636591394/photo/1

#EULAR2024 POS0742 A single cohort study showed for non-criteria #APS, cardiac manifestation (valvular dysfunction & regurgitation) was more common in Triple Ab+ vs Non-Triple Ab. We should monitor and consider an echocardiogram for this group of patient @RheumNow https://t.co/VxFUSpjaG1

• https://twitter.com/Yuz6Yusof/status/1801658685774598633/photo/1

If your GCA flares, do you get the same features as you did at diagnosis? 20% of the time it can be new, so keep on doing the checklist! (also, visual flares uncommon - the power of pred) #EULAR2024 POS0110 @MayoClinic @MdWarrington @RheumNow https://t.co/hkF8vJT6HI

• https://twitter.com/drdavidliew/status/1801639574403486147/photo/1
• https://twitter.com/drdavidliew/status/1801639574403486147/photo/1

Just a reminder - large vessel involvement is very common in GCA, and lines up with aortic dilatation. And if you don’t look, you won’t find… #EULAR2024 POS0932 @RheumNow https://t.co/2uZTu0B18Z

• https://twitter.com/drdavidliew/status/1801599623754105192/photo/1

Prof Hellmich takes us through “What is new?” In ANCA #vasculitis A tour de force in management strategies and, continuing a theme of #EULAR2024, ends with a study suggesting the potential of #CAR-T! @RheumNow https://t.co/K3dDqZhUvD

• https://twitter.com/DrMiniDey/status/1801589388272390545/photo/1

Predicting who will develop ▶️#GCA In #Swedish study with #PMR ⬆️ in HIGH ESR/CRP ⬆️female ⬇️ if hip pain/stiffness Not all sig 1 mo after #prednisone started Only 9% with #polymyalgia #rheumatica developed #GCA ? ⬇️GCA % in PMR over time #POS0411 @eular_org @RheumNow https://t.co/UMhxlYd0Pv

• https://twitter.com/Janetbirdope/status/1801542496675143886/photo/1

Leflunomide for #PMR? ✅ #Leflunomide FAR more effective than #MTX in #polymyalgia #rheumatica V fast withdrawal of #prednisone #LEF ~4 to 5 months #MTX 30 mos! ⬇️flares w LEF 😮 #EULAR2024 @RheumNow @eular_org @SebaUltraTrail https://t.co/2hk0yMH6gY

• https://twitter.com/Janetbirdope/status/1801533348843573456/photo/1
• https://twitter.com/Janetbirdope/status/1801533348843573456/photo/1

Does TCZ switch off GCA histopathologically? GCA pts still on TCZ (median 2.4y duration) had repeat temporal artery biopsy (contralat) Despite serological remission on TCZ, a heap had active histopath findings & PET still active. Scary #EULAR2024 OP0233 Reggio Emilia @RheumNow https://t.co/TKBUP5p4R0

• https://twitter.com/drdavidliew/status/1801548741305880971/photo/1
• https://twitter.com/drdavidliew/status/1801548741305880971/photo/1
• https://twitter.com/drdavidliew/status/1801548741305880971/photo/1

#Editor’s #Choice @MatsJunek Who #relapses in #ANCA #vasculitis In #Pexivas trial #Renal #failure may be protective from relapses. Seems to be the case in renal #lupus #GN too~my opinion ?Why 🤷 #EULAR2024 #EULARBEST @ARD_BMJ @RheumNow @eular_org @ACR_Journals https://t.co/kUD1qjnwqE

• https://twitter.com/Janetbirdope/status/1801224961371103588/photo/1
• https://twitter.com/Janetbirdope/status/1801224961371103588/photo/1
• https://twitter.com/Janetbirdope/status/1801224961371103588/photo/1

I have to say: upadacitinib looks very decent for GCA. Not a panacea, but it definitely does something & good safety during trial. Would love to eventually see: - H2H comparative effect vs toci, secukinumab - structural outcomes - long-term safety #EULAR2024 PBA0001 @RheumNow https://t.co/pHZgCKsoA9 https://t.co/5BxCkkLPti

• https://twitter.com/drdavidliew/status/1801223940318351737/photo/1
• https://twitter.com/drdavidliew/status/1801223940318351737/photo/1
• https://twitter.com/drdavidliew/status/1801223940318351737/photo/1
• https://twitter.com/drdavidliew/status/1801223940318351737/photo/1
• https://twitter.com/drdavidliew/status/1801196482995101974

LONG-TERM EFFICACY TOCILIZUMAB AFTER ULTRA-SHORT GC TO TREAT GCA: 3 Yr FOLLOW-UP OF THE GUSTO TRIAL 3 day GC pulse immediate 12 mths Toci 85% drug free remission at 4 yrs! @rheumnow #EULAR2024